Table 1. Baseline characteristics of TB patients at Temeke district by choice of DOT.
| Characteristics | All | Home-based | Facility-based | p-value |
|---|---|---|---|---|
| (n = 4,835) | (n = 3,593) | (n = 1,242) | ||
| n (%) | n (%) | n (%) | ||
| Proportion of diagnosis, n (%) | 4,835 (100) | 3,593 (100) | 1,242 (100) | |
| Sex | <0.001 | |||
| Male | 2,943 (60.9) | 2,082 (57.9) | 861 (69.3) | |
| Female | 1,892 (39.1) | 1,511 (42.1) | 381 (30.7) | |
| Age in years, median (IQR) | 35 (27–44) | 35 (29–45) | 34 (28–41) | 0.007a |
| Age groups (years) | <0.001 | |||
| 15–19 | 285 (5.9) | 238 (6.6) | 47 (3.8) | |
| 20–24 | 544 (11.3) | 390 (10.9) | 154 (12.4) | |
| 25–29 | 724 (15.0) | 521 (14.5) | 203 (16.3) | |
| 30–34 | 820 (17.0) | 577 (16.1) | 243 (19.6) | |
| 35–39 | 706 (14.6) | 521 (14.5) | 185 (14.9) | |
| 40–44 | 570 (11.8) | 405 (11.3) | 165 (13.3) | |
| 45–49 | 428 (8.9) | 319 (8.9) | 109 (8.8) | |
| 50–54 | 279 (5.8) | 218 (6.1) | 61 (4.9) | |
| ≥55 | 479 (9.9) | 404 (11.2) | 75 (6.0) | |
| HIV status | 0.002 | |||
| Positive | 1,927 (39.9) | 1,485 (41.3) | 442 (35.6) | |
| Negative | 2,582 (53.4) | 1,874 (52.2) | 708 (57.0) | |
| Unknown status | 326 (6.7) | 234 (6.5) | 92 (7.4) | |
| Site of disease | <0.001 | |||
| PTB | 3,977 (82.3) | 2,884 (80.3) | 1,093 (88.0) | |
| EPTB | 858 (17.7) | 709 (19.7) | 149 (12.0) | |
| Category | <0.001 | |||
| New | 4,706 (97.3) | 3,557 (99.0) | 1,149 (92.5) | |
| Retreatment | 129 (2.7) | 36 (1.0) | 93 (7.5) | |
| AFB smear result at diagnosis | <0.001 | |||
| Smear-positive | 2,438 (50.4) | 1,706 (47.5) | 732 (58.9) | |
| Smear-negative | 2,352 (48.6) | 1,845 (51.3) | 507 (40.8) | |
| Unknown | 47 (0.9) | 42 (1.2) | 3 (0.2) |
aWilcox-ranksum test; n (%), absolute number and column percentage
Patients with unknown DOT preference were excluded (n = 31, 0.6%).
AFB, acid-fast bacilli; IQR, Interquartile Range; HIV, Human Immunodeficieny Virus; TB, Tuberculosis; PTB, Pulmonary tuberculosis; EPTB, Extrapulmonary tuberculosis; DOT, Directly Observed Treatment.